Ovid Therapeutics Inc. - COM (OVID)

Historical Portfolio Holders from Q2 2017 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	42.4 M	$129 M	-$4.52 M	915	18 K	$3.05	77
2023 Q4	44 M	$142 M	+$7.87 M		7.08 K	$3.22	73
2023 Q3	42.3 M	$163 M	+$5.68 M	0	0	$3.84	62
2023 Q2	41 M	$134 M	+$8.71 M	656	31.5 K	$3.28	67
2023 Q1	38.7 M	$99.8 M	+$650 K	516	28.4 K	$2.58	58
2022 Q4	38.6 M	$71.7 M	+$2.58 M		17.1 K	$1.86	55
2022 Q3	33.9 M	$62.3 M	+$1.74 M		43 K	$1.84	50
2022 Q2	34.2 M	$73.5 M	-$3 M		76 K	$2.15	51
2022 Q1	35.1 M	$110 M	+$3.43 M		175 K	$3.14	57
2021 Q4	34 M	$109 M	+$1.31 M	0	540 K	$3.21	61
2021 Q3	33.6 M	$113 M	+$499 K	209 K	769 K	$3.36	68
2021 Q2	33.2 M	$130 M	-$11.5 M	206 K	1.15 M	$3.91	75
2021 Q1	32.7 M	$132 M	+$41 M	1.08 M	986 K	$4.02	81
2020 Q4	24.8 M	$57.3 M	-$5.6 M	590 K	79 K	$2.31	71
2020 Q3	25.1 M	$144 M	+$11.2 M	428 K	676 K	$5.74	89
2020 Q2	19.7 M	$145 M	+$45.8 M	396 K	595 K	$7.37	75
2020 Q1	13.6 M	$40.5 M	-$7.1 M			$2.98	51
2019 Q4	17.7 M	$73.6 M	+$38.2 M			$4.15	56
2019 Q3	8.2 M	$26.6 M	-$5.12 M			$3.24	36
2019 Q2	10.1 M	$18.7 M	-$3.46 M			$1.85	31
2019 Q1	11.2 M	$19.8 M	+$9.09 M			$1.77	44
2018 Q4	6.84 M	$16.5 M	-$8.55 M			$2.42	45
2018 Q3	6.68 M	$37.9 M	-$3.04 M			$5.67	45
2018 Q2	6.99 M	$54.5 M	-$351 K			$7.80	43
2018 Q1	7.05 M	$49.8 M	-$9.28 M			$7.07	48
2017 Q4	7.82 M	$77.2 M	+$5.97 M			$9.87	48
2017 Q3	7.22 M	$61.5 M	-$6.77 M			$8.57	42
2017 Q2	7.96 M	$81.5 M	+$81.5 M			$10.49	42